Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
129,668,560
Number of holders
247
Total 13F shares, excl. options
122,630,250
Shares change
-1,334,372
Total reported value, excl. options
$2,020,773,423
Value change
-$19,292,481
Put/Call ratio
14%
Number of buys
91
Number of sells
-129
Price
$16.48

Significant Holders of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) as of Q4 2024

293 filings reported holding NEO - NEOGENOMICS INC - Common Stock, par value $0.001 per share as of Q4 2024.
NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) has 247 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 122,630,250 shares of 129,668,560 outstanding shares and own 95% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (20,243,667 shares), VANGUARD GROUP INC (14,239,887 shares), T. Rowe Price Investment Management, Inc. (6,528,111 shares), JANUS HENDERSON GROUP PLC (6,165,063 shares), BROWN ADVISORY INC (6,156,061 shares), STATE STREET CORP (5,198,487 shares), Greenhouse Funds LLLP (4,701,897 shares), MACQUARIE GROUP LTD (3,812,229 shares), SCHRODER INVESTMENT MANAGEMENT GROUP (3,800,215 shares), and DIMENSIONAL FUND ADVISORS LP (3,436,858 shares).
This table shows the top 247 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.